(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MULTIPHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MULTIPHARMA

ST13

US500000079087819

Class

35

Filing

79087819

Registration

4054566

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

04/04/2023

Trademark type

Word

Nice classes

35

Filing date

06/28/2010

Registration date

11/15/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/27/2022

Last transaction

05/27/2022

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

LU

Examiner

SNAPP, TINA LOUISE

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Inceptua S.A.
MULTIPHARMA S.A.
MULTIPHARMA GmbH

Representatives

Joseph F. Schmidt Taft Stettinius & Hollister LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Advertising; business management; import-export agencies; business management for others; wholesale store services featuring medicinesmedicalorthopaedic and cosmetic products

Publications

History of USPTO decisions and trademark events.

42 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

04/04/2023

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

03/16/2023

INPC

INVALIDATION PROCESSED

03/16/2023

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

01/27/2023

C71T

CANCELLED SECTION 71

05/27/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

11/15/2020

RNWL

INTERNATIONAL REGISTRATION RENEWED

07/16/2020

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/07/2017

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

06/24/2017

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

06/24/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/23/2017

ES75

TEAS SECTION 71 & 15 RECEIVED

05/03/2017

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/16/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/31/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/06/2012

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/20/2012

FIMP

FINAL DISPOSITION PROCESSED

06/20/2012

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/15/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

11/15/2011

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

10/13/2011

GPNX

NOTIFICATION PROCESSED BY IB

08/20/2011

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

07/22/2011

CHLD

CHANGE OF OWNER RECEIVED FROM IB

07/11/2011

PUBO

PUBLISHED FOR OPPOSITION

06/07/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/18/2011

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/18/2011

NPUB

NOTICE OF PUBLICATION

05/18/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/29/2011

ALIE

ASSIGNED TO LIE

04/26/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/12/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/01/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/01/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/01/2011

RFNT

REFUSAL PROCESSED BY IB

11/28/2010

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/05/2010

RFRR

REFUSAL PROCESSED BY MPU

11/05/2010

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/05/2010

CNRT

NON-FINAL ACTION WRITTEN

11/04/2010

MAFR

APPLICATION FILING RECEIPT MAILED

11/02/2010

DOCK

ASSIGNED TO EXAMINER

10/29/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/29/2010

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/28/2010

Continuous trademark protection

Get notified about every new filing that threatens MULTIPHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.